In addition to the extensive research that has been undertaken to standardize and improve the reliability and demonstrate the clinical utility of the Ki-67 immunohistochemical assay in breast cancer, there has also been much research undertaken to try to find alternative methods of measuring Ki-67 or identify new markers that can be used in conjunction with Ki-67. The gene discussed is MKI67; the disease is breast carcinoma.